Endologix, Inc. - NASDAQ: ELGX
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders.
The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement.
Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture.